Targeting met mediated epithelial-mesenchymal transition in the treatment of breast cancer

Mesenchymal epithelial transition factor receptor (Met) is a receptor tyrosine kinase that plays a critical role in promoting cancer cell malignant progression. Met is activated by its ligand hepatocyte growth factor (HGF). HGF-dependent Met activation plays an important role in stimulating epitheli...

Descripción completa

Detalles Bibliográficos
Autor principal: Sylvester, Paul W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883993/
https://www.ncbi.nlm.nih.gov/pubmed/26932375
http://dx.doi.org/10.1186/s40169-014-0030-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883993/
https://www.ncbi.nlm.nih.gov/pubmed/26932375
http://dx.doi.org/10.1186/s40169-014-0030-5

Ejemplares similares